Ghrelin protects infarcted myocardium by induction of autophagy and AMP-activated protein kinase pathway

Biochemical and Biophysical Research Communications

Volumn 476, Issue 4, 2016, Pages 365-370

  Yuan, Ming Jie ^a   Kong, Bin ^a   Wang, Tao ^b   Wang, Xin ^a   Huang, He ^a   Maghsoudi, Taneen ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autophagy; Cardiac function; Ghrelin; Myocardial infarction; Signal pathway

Indexed keywords

AUTOPHAGY PROTEIN 5; GHRELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART FUNCTION; HEART INFARCTION; IN VITRO STUDY; LEFT CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 84973915855     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.05.128     Document Type: Article

References (40)

1. [1] Frangogiannis, N.G., The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11 (2014), 255–265.
2. [2] Frieler, R.A., Mortensen, R.M., Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131 (2015), 1019–1030.
3. [3] Saito, T., Sadoshima, J., Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ. Res. 116 (2015), 1477–1490.
4. [4] Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13 (2007), 619–624.
5. [5] Orogo, A.M., Gustafsson, A.B., Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease. Circ. Res. 116 (2015), 489–503.
6. [6] Wu, X., He, L., Chen, F., He, X., Cai, Y., Zhang, G., et al. Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One, 9, 2014, e112891.
7. [7] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999), 656–660.
8. [8] Virdis, A., Lerman, L.O., Regoli, F., Ghiadoni, L., Lerman, A., Taddei, S., Human ghrelin: a gastric hormone with cardiovascular properties. Curr. Pharm. Des. 22:1 (2016), 52–58.
9. [9] Mao, Y., Tokudome, T., Kishimoto, I., Ghrelin as a treatment for cardiovascular diseases. Hypertension 64 (2014), 450–454.
10. [10] Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159 (2002), 1029–1037.
11. [11] Huang, C.X., Yuan, M.J., Huang, H., Wu, G., Liu, Y., Yu, S.B., et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30 (2009), 2286–2291.
12. [12] Yuan, M.J., He, H., Hu, H.Y., Li, Q., Hong, J., Huang, C.X., Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model. Regul. Pept. 179 (2012), 39–42.
13. [13] Rodriguez, A., Gomez-Ambrosi, J., Catalan, V., Rotellar, F., Valenti, V., Silva, C., et al. The ghrelin O-acyltransferase-ghrelin system reduces TNF-alpha-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia 55 (2012), 3038–3050.
14. [14] Pei, X.M., Yung, B.Y., Yip, S.P., Chan, L.W., Wong, C.S., Ying, M., et al. Protective effects of desacyl ghrelin on diabetic cardiomyopathy. Acta Diabetol. 52 (2015), 293–306.
15. [15] Yuan, H., Niu, Y., Liu, X., Fu, L., Exercise increases the binding of MEF2A to the Cpt1b promoter in mouse skeletal muscle. Acta Physiol. (Oxf.) 212 (2014), 283–292.
16. [16] Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100 (2007), 914–922.
17. [17] Nagaya, N., Uematsu, M., Kojima, M., Ikeda, Y., Yoshihara, F., Shimizu, W., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001), 1430–1435.
18. [18] Frascarelli, S., Ghelardoni, S., Ronca-Testoni, S., Zucchi, R., Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res. Cardiol. 98 (2003), 401–405.
19. [19] Rodriguez, A., Gomez-Ambrosi, J., Catalan, V., Becerril, S., Sainz, N., Gil, M.J., et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J. Hypertens. 28 (2010), 560–567.
20. [20] Gatica, D., Chiong, M., Lavandero, S., Klionsky, D.J., Molecular mechanisms of autophagy in the cardiovascular system. Circ. Res. 116 (2015), 456–467.
21. [21] Nishida, K., Otsu, K., Autophagy during cardiac remodeling. J. Mol. Cell Cardiol., 2015 Dec 8. pii: S0022-2828(15)30142-5.
22. [22] Kanamori, H., Takemura, G., Goto, K., Maruyama, R., Tsujimoto, A., Ogino, A., et al. The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc Res. 91 (2011), 330–339.
23. [23] Kanamori, H., Takemura, G., Goto, K., Maruyama, R., Ono, K., Nagao, K., et al. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 300 (2011), H2261–H2271.
24. [24] Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., Takeyama, T., et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am. J. Pathol. 182 (2013), 701–713.
25. [25] Lu, L., Wu, W., Yan, J., Li, X., Yu, H., Yu, X., Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. Int. J. Cardiol. 134 (2009), 82–90.
26. [26] Kim, J., Kim, Y.C., Fang, C., Russell, R.C., Kim, J.H., Fan, W., et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152 (2013), 290–303.
27. [27] Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60 (2011), 1770–1778.
28. [28] Li, Y., Chen, C., Yao, F., Su, Q., Liu, D., Xue, R., et al. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch. Biochem. Biophys. 558 (2014), 79–86.
29. [29] Sciarretta, S., Volpe, M., Sadoshima, J., Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ. Res. 114 (2014), 549–564.
30. [30] Das, A., Durrant, D., Koka, S., Salloum, F.N., Xi, L., Kukreja, R.C., Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. J. Biol. Chem. 289 (2014), 4145–4160.
31. [31] Li, Q., Xie, J., Li, R., Shi, J., Sun, J., Gu, R., et al. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J. Cell Mol. Med. 18 (2014), 919–928.
32. [32] Wang, X., Wang, X.L., Chen, H.L., Wu, D., Chen, J.X., Wang, X.X., et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochem. Pharmacol. 88 (2014), 334–350.
33. [33] Ruozi, G., Bortolotti, F., Falcione, A., Dal Ferro, M., Ukovich, L., Macedo, A., et al. AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia. Nat. Commun., 6, 2015, 7388.
34. [34] Zhang, M., Fang, W.Y., Qu, X.K., Yuan, F., Wang, W.G., Fei, J., et al. AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice. Int. J. Clin. Exp. Pathol. 6 (2013), 1770–1780.
35. [35] Lopez, M., Lage, R., Saha, A.K., Perez-Tilve, D., Vazquez, M.J., Varela, L., et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 7 (2008), 389–399.
36. [36] He, C., Bassik, M.C., Moresi, V., Sun, K., Wei, Y., Zou, Z., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481 (2012), 511–515.
37. [37] He, C., Zhu, H., Li, H., Zou, M.H., Xie, Z., Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 62 (2013), 1270–1281.
38. [38] Maejima, Y., Kyoi, S., Zhai, P., Liu, T., Li, H., Ivessa, A., et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat. Med. 19 (2013), 1478–1488.
39. [39] Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485 (2012), 251–255.
40. [40] Yuan, M.J., Huang, C.X., Tang, Y.H., Wang, X., Huang, H., Chen, Y.J., et al. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur. J. Pharmacol. 618 (2009), 52–57.